BioCryst Pharmaceuticals | Stock

Aktienkurs
8.80
Täglich Wechseln
0.17 1.91%
Monatlich
36.99%
Jährlich
5.84%
Q1 Prognose
8.48




Stock Veränderung Datum
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
BioCryst Pharmaceuticals USD 5.23M 188K 2025-09
Chugai Pharma JPY 246.33B 10.8B 2025-09
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
Incyte USD 101.06M 17.61M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Karyopharm Therapeutics USD 3.97M 1.03M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novavax USD 13.51M 3.27M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vertex Pharmaceuticals USD 1.69B 60M 2025-12


BioCryst Pharmaceuticals Stock - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.